Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:29 PM
Ignite Modification Date:
2025-12-24 @ 5:29 PM
NCT ID:
NCT06505668
Eligibility Criteria:
Inclusion Criteria:
All patients coming for treatment at the Out-patient department and In-patient department of the Department of Psychiatry fulfilling the following are included:
1. Patients diagnosed with TRS (TRRIP consensus) receiving clozapine.
2. Aged between 18 to 60 years of either sex
3. Having baseline heart rate of \>100/minute.
4. Written informed consent from Legally Authorized representative.
Exclusion Criteria:
Patients with any one of the following are excluded from the study:
1. Already receiving Atenolol or Ivabradine.
2. Patients having any contraindication to using Atenolol or Ivabradine.
3. Receiving any other medication other than Clozapine known to cause autonomic dysregulation.
4. Active substance use.
5. Serious medical or neurological comorbidity.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT06505668
Study Brief:
Protocol Section:
NCT06505668